This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Sonovoice, Inc. in Raleigh, NC aims to develop a novel digital device and smartphone application for comprehensive voice health evaluations. The proposed research will involve iterative prototyping, calibration, and validation with human subjects to ensure the affordability, precision, reliability, and user-friendliness of the multimodal voice assessment tool. The...
The National Institute on Drug Abuse (NIDA) awarded a $586,340 Project Grant (CFDA 93.279, Drug Use and Addiction Research Programs) to Tenvos Inc., a minority-owned and woman-owned small business, to develop an artificial intelligence-based technology that can remotely detect opioid use by analyzing 15 seconds of a person's speech. The project aims to further develop Tenvos' solution and understand how opioid use affects vocal characteristics, while comparing the detection method to current...
The National Science Foundation Division of Industrial Innovation awarded Kintsugi Mindful Wellness, Inc. a $1.5 million cooperative agreement under the SBIR PHASE II program titled "AUGMENTING VIRTUAL HEALTHCARE WITH VOICE BIOMARKERS" from May 2021 through April 2025. Under this award, Kintsugi will develop and deliver products and services augmenting virtual healthcare with voice biomarker technology. The NSF Directorate for Engineering seeks to improve quality of life and economic...
The National Institute on Drug Abuse (NIDA) awarded a $800,000 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Tenvos Inc., a minority-owned and woman-owned technology company. The grant will support the development of a software-based medical device (SAMD) integrated into a smartphone application that can detect opioid use through voice analysis. The proposed solution aims to enable patients in outpatient opioid use disorder (OUD) treatment to remotely test for...
This $999,994 cooperative agreement from the National Science Foundation under the Technology, Innovation, and Partnerships program will support Deepconvo Inc.'s development of voice-based telehealth products and services for respiratory disease monitoring and screening. Deepconvo will further develop its chronic obstructive pulmonary disease early exacerbation warning system to more accurately measure lung function deterioration through voice and breath data captured on mobile phones. Key...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Technology Transfer (STTR) Project Grant, awarded to Ai-Neotech LLC in the amount of $275,000 on October 1, 2023, supports the development of a novel consumer product that uses artificial intelligence (AI) and machine learning (ML) models applied to electroencephalogram (EEG) data to predict and mitigate the risk of epileptic seizures for patients and their caregivers. The goal is...
This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) aims to develop an AI-powered data platform to address the challenge of "dark data" in materials science. The project by FUM Technologies, Inc., a small disadvantaged business located in Cambridge, MA, seeks to create a conversational digital expert system that can extract and synthesize valuable...
The National Science Foundation awarded $276,000 under the Technology, Innovation, and Partnerships federal grant program to Oneseventeen Media PBC for its SBIR Phase I project titled "An Intelligent Mental Health Care Companion for Kids." The project aims to develop a mobile-accessed system leveraging machine learning and cognitive behavioral therapies to detect and triage symptoms of loneliness, anger, anxiety, and depression in children ages 10-18. The system will utilize chatbots...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) grant award of $303,089 to Bioimaginix LLC, a small business, aims to develop an AI-powered diagnostic tool for early detection of Alzheimer's disease (AD) and mild cognitive impairment (MCI) using magnetic resonance imaging (MRI) scans. The project utilizes a specialized AI/machine learning algorithm to analyze 3D structural MRI brain scans and detect changes associated with brain atrophy...
This Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $999,878 to Akttyva Therapeutics, Inc., a small business located in Watertown, MA, to develop an AI-assisted drug discovery platform to identify existing drugs and new chemical entities capable of repairing vascular permeability barriers. The project aims to address unmet clinical needs for conditions like acute respiratory distress...